An allograft is bone graft material processed from human donor bone obtained from accredited tissue banks. The bone is screened, processed, and sterilized to remove all living cells and pathogens while preserving the mineral scaffold and growth factor proteins. It is widely used in dental bone grafting for socket preservation, ridge augmentation, and sinus lifts.

A xenograft is bone graft material derived from an animal source — most commonly bovine (cow) bone. It is processed to remove all organic material (proteins, cells, lipids), leaving a pure mineral scaffold. This scaffold is biocompatible, has a microstructure similar to human bone, and resorbs very slowly, providing long-term volume maintenance at the graft site.

Yes. Allograft bone from accredited tissue banks undergoes rigorous donor screening, serological testing, and multi-step processing (freeze-drying, irradiation, or chemical treatment). The risk of disease transmission is estimated at less than 1 in 1.6 million — lower than many commonly accepted medical risks. Millions of allograft procedures are performed annually with an excellent safety record.

Yes. Xenograft processing removes all organic material, eliminating the risk of immune rejection or disease transmission (including BSE/mad cow disease). The remaining mineral scaffold is chemically inert and highly biocompatible. Deproteinized bovine bone mineral has been used in dental and orthopedic surgery for over 30 years with extensively documented safety.

FDBA (freeze-dried bone allograft) is processed to preserve the mineral content of the bone, making it a good scaffold that resorbs at a moderate rate. DFDBA (demineralized freeze-dried bone allograft) has the mineral component removed, exposing bone morphogenetic proteins (BMPs) that actively stimulate new bone formation. DFDBA is more osteoinductive but provides less structural support.

Using donor materials avoids the need for a second surgical site (chin or ramus harvest), which means less pain, less surgical time, and no donor site morbidity. For most grafting situations — socket preservation, moderate ridge augmentation, sinus lifts — allograft and xenograft produce results comparable to autogenous bone with less patient discomfort.

Autogenous bone is preferred for severe defects requiring large-volume augmentation, vertical ridge augmentation, and situations where maximum osteogenic potential is needed. These scenarios benefit from the living cells in autogenous bone that allograft and xenograft cannot provide. For most routine grafting, allograft and xenograft are excellent alternatives.

True allergic reactions to properly processed allograft and xenograft are extremely rare. The processing removes the proteins that typically trigger immune responses. Occasional inflammatory reactions can occur, but these are related to normal wound healing rather than an allergic mechanism. If you have known allergies to specific materials, inform us during your consultation.

Allograft integrates (is replaced by new bone) over 4-6 months. Xenograft resorbs much more slowly — some particles remain detectable years after placement. The clinical significance is that xenograft maintains volume long-term (beneficial in sinus lifts and large augmentations), while allograft is replaced more rapidly by living bone.

PRF (platelet-rich fibrin) is prepared from your own blood and concentrated with growth factors. When mixed with allograft and xenograft particles, PRF provides osteoinductive signaling that these materials may lack, improves handling (the graft becomes sticky and easier to place), promotes blood vessel formation within the graft, and accelerates healing. It bridges the biological gap between off-the-shelf materials and your body's healing machinery.

The decision is based on the type and size of the defect, the intended purpose (socket preservation vs. sinus lift vs. ridge augmentation), the need for volume maintenance vs. rapid resorption, and the biological environment at the site. Dr. Ostovar selects materials based on clinical evidence and his experience with how each material performs in specific situations.

Cost depends on the procedure (socket graft, sinus lift, GBR) and the volume of material needed. Graft materials are a component of the overall procedure fee. Allograft and xenograft costs are comparable. The total procedure fee reflects the surgical technique, materials, membrane, PRF, and sedation. Specific estimates are provided after consultation.

Allograft bone is regulated by the FDA as human tissue under 21 CFR Part 1271. Xenograft materials (like Bio-Oss) are FDA-cleared medical devices (510(k)). Both categories are subject to manufacturing standards, quality control, and safety testing. We use materials only from reputable manufacturers with established safety records.

Yes. Combining allograft and xenograft is a common and effective strategy. The allograft provides osteoinductive growth factors for early bone formation. The xenograft provides long-term scaffold stability due to its slow resorption. This combination is particularly effective in sinus lifts and larger augmentations.

We understand these concerns. Alternatives include synthetic graft materials (calcium phosphate, hydroxyapatite, bioactive glass) that contain no human or animal components. While synthetics are purely osteoconductive (no growth factors), they perform well in many clinical situations. Another option is autogenous bone from your own jaw. Dr. Ostovar will discuss all material options with you.